Marc Phares of Epic Studios, Inc. partnered recently with GHG Summit to create a whimsical illustration for Yosprala™. Art Directors: Tom Browne and Jonathan Coleman. A spin-off promo sculpture was also created utilizing the 3d models and illustration.

Yosprala™ is a combination of aspirin, an anti-platelet agent, and omeprazole, a proton pump inhibitor (PPI), indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers.

YOSPRALA